Free Trial
NASDAQ:CYCN

Cyclerion Therapeutics (CYCN) Stock Price, News & Analysis

Cyclerion Therapeutics logo
$3.30 +0.01 (+0.15%)
As of 07/3/2025 02:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Cyclerion Therapeutics Stock (NASDAQ:CYCN)

Key Stats

Today's Range
$3.06
$3.43
50-Day Range
$2.75
$3.70
52-Week Range
$1.27
$9.47
Volume
19,378 shs
Average Volume
1.28 million shs
Market Capitalization
$10.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CYCN Stock News Headlines

Cyclerion Therapeutics files $25M mixed securities shelf
3 US Penny Stocks With Market Caps Over $10M To Consider
Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
Cyclerion Therapeutics announces update on next stage of growth
See More Headlines

CYCN Stock Analysis - Frequently Asked Questions

Cyclerion Therapeutics' stock was trading at $3.22 at the beginning of 2025. Since then, CYCN stock has increased by 2.6% and is now trading at $3.3050.

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) issued its quarterly earnings data on Tuesday, March, 4th. The company reported $0.22 earnings per share for the quarter. The company had revenue of $1.81 million for the quarter.

Cyclerion Therapeutics shares reverse split on Tuesday, May 16th 2023.The 1-20 reverse split was announced on Tuesday, May 16th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 16th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of CYCN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cyclerion Therapeutics investors own include Meta Platforms (META), NVIDIA (NVDA), GE Aerospace (GE), CymaBay Therapeutics (CBAY), Advanced Micro Devices (AMD), Adobe (ADBE) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
3/04/2025
Today
7/06/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CYCN
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.06 million
Pretax Margin
-141.47%

Debt

Sales & Book Value

Annual Sales
$2 million
Price / Cash Flow
N/A
Book Value
$3.27 per share
Price / Book
1.01

Miscellaneous

Free Float
2,109,000
Market Cap
$10.61 million
Optionable
No Data
Beta
1.55
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:CYCN) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners